vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and SS&C Technologies Holdings Inc (SSNC). Click either name above to swap in a different company.
SS&C Technologies Holdings Inc is the larger business by last-quarter revenue ($1.6B vs $950.5M, roughly 1.7× Astrana Health, Inc.). SS&C Technologies Holdings Inc runs the higher net margin — 13.7% vs 0.7%, a 13.0% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 8.8%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 6.5%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
SS&C Technologies Holdings, Inc. is an American multinational holding company headquartered in Windsor, Connecticut, that sells software and software as a service to the financial services industry. The company has offices in the Americas, Europe, Asia, Africa and Australia.
ASTH vs SSNC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.6B |
| Net Profit | $6.6M | $226.1M |
| Gross Margin | — | 48.7% |
| Operating Margin | 1.9% | 24.2% |
| Net Margin | 0.7% | 13.7% |
| Revenue YoY | 42.9% | 8.8% |
| Net Profit YoY | 184.4% | 6.2% |
| EPS (diluted) | $0.12 | $0.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.6B | ||
| Q4 25 | $950.5M | $1.7B | ||
| Q3 25 | $956.0M | $1.6B | ||
| Q2 25 | $654.8M | $1.5B | ||
| Q1 25 | $620.4M | $1.5B | ||
| Q4 24 | $665.2M | $1.5B | ||
| Q3 24 | $478.7M | $1.5B | ||
| Q2 24 | $486.3M | $1.5B |
| Q1 26 | — | $226.1M | ||
| Q4 25 | $6.6M | $193.1M | ||
| Q3 25 | $373.0K | $210.0M | ||
| Q2 25 | $9.4M | $180.8M | ||
| Q1 25 | $6.7M | $213.0M | ||
| Q4 24 | $-7.8M | $248.2M | ||
| Q3 24 | $16.1M | $164.4M | ||
| Q2 24 | $19.2M | $190.3M |
| Q1 26 | — | 48.7% | ||
| Q4 25 | — | 47.8% | ||
| Q3 25 | — | 47.7% | ||
| Q2 25 | — | 48.0% | ||
| Q1 25 | — | 49.3% | ||
| Q4 24 | — | 49.3% | ||
| Q3 24 | — | 48.0% | ||
| Q2 24 | — | 48.1% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | 1.9% | 22.3% | ||
| Q3 25 | 2.0% | 23.3% | ||
| Q2 25 | 3.1% | 22.4% | ||
| Q1 25 | 3.3% | 23.6% | ||
| Q4 24 | 0.1% | 23.4% | ||
| Q3 24 | 5.9% | 22.2% | ||
| Q2 24 | 6.2% | 22.6% |
| Q1 26 | — | 13.7% | ||
| Q4 25 | 0.7% | 11.7% | ||
| Q3 25 | 0.0% | 13.4% | ||
| Q2 25 | 1.4% | 11.8% | ||
| Q1 25 | 1.1% | 14.1% | ||
| Q4 24 | -1.2% | 16.2% | ||
| Q3 24 | 3.4% | 11.2% | ||
| Q2 24 | 3.9% | 13.1% |
| Q1 26 | — | $0.91 | ||
| Q4 25 | $0.12 | $0.76 | ||
| Q3 25 | $0.01 | $0.83 | ||
| Q2 25 | $0.19 | $0.72 | ||
| Q1 25 | $0.14 | $0.84 | ||
| Q4 24 | $-0.14 | $0.98 | ||
| Q3 24 | $0.33 | $0.65 | ||
| Q2 24 | $0.40 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $420.9M |
| Total DebtLower is stronger | — | $7.4B |
| Stockholders' EquityBook value | $779.3M | $6.9B |
| Total Assets | $2.2B | $20.3B |
| Debt / EquityLower = less leverage | — | 1.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $420.9M | ||
| Q4 25 | $429.5M | $462.1M | ||
| Q3 25 | $463.4M | $388.3M | ||
| Q2 25 | $342.1M | $480.3M | ||
| Q1 25 | $260.9M | $515.0M | ||
| Q4 24 | $290.8M | $567.1M | ||
| Q3 24 | $350.3M | $694.7M | ||
| Q2 24 | $327.7M | $462.7M |
| Q1 26 | — | $7.4B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $6.9B | ||
| Q4 25 | $779.3M | $6.9B | ||
| Q3 25 | $775.5M | $6.9B | ||
| Q2 25 | $765.5M | $6.9B | ||
| Q1 25 | $745.4M | $6.8B | ||
| Q4 24 | $712.7M | $6.5B | ||
| Q3 24 | $704.6M | $6.8B | ||
| Q2 24 | $678.9M | $6.4B |
| Q1 26 | — | $20.3B | ||
| Q4 25 | $2.2B | $20.7B | ||
| Q3 25 | $2.2B | $19.5B | ||
| Q2 25 | $1.4B | $19.0B | ||
| Q1 25 | $1.3B | $20.4B | ||
| Q4 24 | $1.4B | $19.0B | ||
| Q3 24 | $1.3B | $18.4B | ||
| Q2 24 | $1.3B | $16.9B |
| Q1 26 | — | 1.08× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $299.7M |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.33× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $299.7M | ||
| Q4 25 | $-2.9M | $643.5M | ||
| Q3 25 | $10.0M | $456.2M | ||
| Q2 25 | $90.9M | $372.9M | ||
| Q1 25 | $16.6M | $272.2M | ||
| Q4 24 | $-10.9M | $486.6M | ||
| Q3 24 | $34.0M | $336.6M | ||
| Q2 24 | $23.2M | $384.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $633.0M | ||
| Q3 25 | $7.4M | $421.5M | ||
| Q2 25 | $89.5M | $350.0M | ||
| Q1 25 | $13.6M | $259.5M | ||
| Q4 24 | $-13.5M | $466.9M | ||
| Q3 24 | $31.7M | $310.7M | ||
| Q2 24 | $20.4M | $374.9M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 38.3% | ||
| Q3 25 | 0.8% | 26.9% | ||
| Q2 25 | 13.7% | 22.8% | ||
| Q1 25 | 2.2% | 17.1% | ||
| Q4 24 | -2.0% | 30.5% | ||
| Q3 24 | 6.6% | 21.2% | ||
| Q2 24 | 4.2% | 25.8% |
| Q1 26 | — | 0.0% | ||
| Q4 25 | 0.3% | 0.6% | ||
| Q3 25 | 0.3% | 2.2% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.5% | 0.8% | ||
| Q4 24 | 0.4% | 1.3% | ||
| Q3 24 | 0.5% | 1.8% | ||
| Q2 24 | 0.6% | 0.7% |
| Q1 26 | — | 1.33× | ||
| Q4 25 | -0.44× | 3.33× | ||
| Q3 25 | 26.69× | 2.17× | ||
| Q2 25 | 9.65× | 2.06× | ||
| Q1 25 | 2.48× | 1.28× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | 2.11× | 2.05× | ||
| Q2 24 | 1.21× | 2.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SSNC
| Technology-enabled services | $1.4B | 85% |
| License, maintenance and related | $239.8M | 15% |
